579 related articles for article (PubMed ID: 18507055)
1. The clinicopathological and prognostic significance of MUC-1 expression in Japanese gastric carcinomas: an immunohistochemical study of tissue microarrays.
Li XH; Zheng HC; Wang ZG; Takahashi H; Yang XH; Guan YF; Takano Y
Anticancer Res; 2008; 28(2A):1061-7. PubMed ID: 18507055
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of cortactin and fascin are effective markers for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas.
Li X; Zheng H; Hara T; Takahashi H; Masuda S; Wang Z; Yang X; Guan Y; Takano Y
Int J Oncol; 2008 Jul; 33(1):69-79. PubMed ID: 18575752
[TBL] [Abstract][Full Text] [Related]
3. Arp2/3 overexpression contributed to pathogenesis, growth and invasion of gastric carcinoma.
Zheng HC; Zheng YS; Li XH; Takahashi H; Hara T; Masuda S; Yang XH; Guan YF; Takano Y
Anticancer Res; 2008; 28(4B):2225-32. PubMed ID: 18751399
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological and prognostic significance of MUC-2, MUC-4 and MUC-5AC expression in japanese gastric carcinomas.
Xiao LJ; Zhao S; Zhao EH; Zheng X; Gou WF; Xing YN; Takano Y; Zheng HC
Asian Pac J Cancer Prev; 2012; 13(12):6447-53. PubMed ID: 23464473
[TBL] [Abstract][Full Text] [Related]
6. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression.
Yu M; Zheng H; Tsuneyama K; Takahashi H; Nomoto K; Xu H; Takano Y
Hum Pathol; 2007 Aug; 38(8):1248-55. PubMed ID: 17490717
[TBL] [Abstract][Full Text] [Related]
7. MUC6 down-regulation correlates with gastric carcinoma progression and a poor prognosis: an immunohistochemical study with tissue microarrays.
Zheng H; Takahashi H; Nakajima T; Murai Y; Cui Z; Nomoto K; Tsuneyama K; Takano Y
J Cancer Res Clin Oncol; 2006 Dec; 132(12):817-23. PubMed ID: 16807756
[TBL] [Abstract][Full Text] [Related]
8. [Expression and significance of RhoA and NF-ΚB in human gastric carcinoma].
Su XJ; Tang ZF; Li Q; Li HL; Li LL; Liu M; Zhou YN
Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):276-9. PubMed ID: 21575498
[TBL] [Abstract][Full Text] [Related]
9. Expression of MUC2 in gastric carcinomas and background mucosae.
Lee HW; Yang DH; Kim HK; Lee BH; Choi KC; Choi YH; Park YE
J Gastroenterol Hepatol; 2007 Aug; 22(8):1336-43. PubMed ID: 17559374
[TBL] [Abstract][Full Text] [Related]
10. Nuclear or cytoplasmic localization of Bag-1 distinctly correlates with pathologic behavior and outcome of gastric carcinomas.
Zheng HC; Xu XY; Xing YN; Wei ZL; Takahashi H; Masuda S; Takano Y
Hum Pathol; 2010 May; 41(5):724-36. PubMed ID: 20096920
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of the cyclooxygenase-2 (COX-2) in gastric cancer. The correlations with the tumor angiogenesis and patients' survival.
Lazăr D; Tăban S; Ardeleanu C; Simionescu C; Sporea I; Cornianu M; Vernic C
Rom J Morphol Embryol; 2008; 49(3):371-9. PubMed ID: 18758643
[TBL] [Abstract][Full Text] [Related]
12. The altered expression of ING5 protein is involved in gastric carcinogenesis and subsequent progression.
Xing YN; Yang X; Xu XY; Zheng Y; Xu HM; Takano Y; Zheng HC
Hum Pathol; 2011 Jan; 42(1):25-35. PubMed ID: 21062663
[TBL] [Abstract][Full Text] [Related]
13. The immunohistochemical expression of E-cadherin in gastric cancer; correlations with clinicopathological factors and patients' survival.
Lazăr D; Tăban S; Ardeleanu C; Dema A; Sporea I; Cornianu M; Lazăr E; Vernic C
Rom J Morphol Embryol; 2008; 49(4):459-67. PubMed ID: 19050793
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and prognostic significance of mucin phenotype in gastric cancer.
Wakatsuki K; Yamada Y; Narikiyo M; Ueno M; Takayama T; Tamaki H; Miki K; Matsumoto S; Enomoto K; Yokotani T; Nakajima Y
J Surg Oncol; 2008 Aug; 98(2):124-9. PubMed ID: 18521835
[TBL] [Abstract][Full Text] [Related]
15. Distinction of differentiated type early gastric carcinoma with gastric type mucin expression.
Koseki K; Takizawa T; Koike M; Ito M; Nihei Z; Sugihara K
Cancer; 2000 Aug; 89(4):724-32. PubMed ID: 10951333
[TBL] [Abstract][Full Text] [Related]
16. Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients.
Utsunomiya T; Yonezawa S; Sakamoto H; Kitamura H; Hokita S; Aiko T; Tanaka S; Irimura T; Kim YS; Sato E
Clin Cancer Res; 1998 Nov; 4(11):2605-14. PubMed ID: 9829723
[TBL] [Abstract][Full Text] [Related]
17. Role of MUC1 and MUC5AC expressions as prognostic indicators in gastric carcinomas.
Wang JY; Chang CT; Hsieh JS; Lee LW; Huang TJ; Chai CY; Lin SR
J Surg Oncol; 2003 Aug; 83(4):253-60. PubMed ID: 12884239
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between Ets-1 expression and angiogenesis, clinicopathological features and survival of patients with gastric carcinoma].
Ren TW; Zhou YN; Wu J; Zhang ZY; Hao TJ; Wang JX; Zou SJ; Chen ZF; Huang SS; Zhang LH; Zhao Y
Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):674-8. PubMed ID: 20021863
[TBL] [Abstract][Full Text] [Related]
19. Combined evaluation of mucin antigen and E-cadherin expression may help select patients with gastric cancer suitable for minimally invasive therapy.
Tanaka M; Kitajima Y; Sato S; Miyazaki K
Br J Surg; 2003 Jan; 90(1):95-101. PubMed ID: 12520583
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological significance and survival influence of p53 protein expression in gastric carcinoma.
Pinto-de-Sousa J; Silva F; David L; Leitão D; Seixas M; Pimenta A; Cardoso-de-Oliveira M
Histopathology; 2004 Apr; 44(4):323-31. PubMed ID: 15049897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]